Because YAP/TAZ-TEAD transcriptional activity governs RAD51 expression in cancer cells [36], whether SOX5 inhibition regulates YAP and the HR repair genes, BRCA1 and RAD51, in olaparib-resistant cells was investigated. The gene discussed is RAD51; the disease is cancer.